Pulsed-dye Laser Treatment Prior to Surgical Excision

Status Recruiting

Clinical Trial Summary

This prospective pilot study will investigate whether use of a pulsed dye laser (PDL) prior to surgical excision can improve the appearance and symptoms of scars. The primary outcome measurement for the study is the quality of the scar in areas pre-treated with PDL vs. control (cryogen spray only). For this study, subjects who are scheduled for a dermatologic surgical excision will have half of the surgical area pre-treated with PDL and the other half pre-treated with cryogen spray.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Cicatrix

Clinical Trial Details

NCT number	NCT02458976
Study type	Interventional
Source	Massachusetts General Hospital
Contact	Kachiu Lee, MD
Phone	617-371-4711
Email	klee52@mgh.harvard.edu
Status	Recruiting
Phase	N/A
Start date	June 2015
Completion date	July 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02645773` - Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring	N/A
Completed	`NCT02672956` - Comparison of Different Umbilical Port Entry Techniques in Terms of Cosmetic Results	N/A
Completed	`NCT00629811` - Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and Women	Phase 2
Completed	`NCT00977951` - Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male Subjects	Phase 1/Phase 2
Completed	`NCT00847795` - Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.	Phase 1/Phase 2
Not yet recruiting	`NCT03213548` - Aesthetic and Functional Results of Alar Base Modifications in Rhinoplasty	N/A
Recruiting	`NCT05377723` - Abdominal Scar Improvement in Microsurgical Breast Reconstruction	N/A
Active, not recruiting	`NCT01976260` - A Pilot Study Testing Fractional Radiofrequency Versus Fractional Photothermolysis for the Treatment of Acne Scars	N/A
Terminated	`NCT00432328` - Juvista (Avotermin) in Breast Reduction Surgery Scars	Phase 2
Completed	`NCT00594581` - Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy Males	Phase 2
Completed	`NCT00984503` - Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor Sites	Phase 2
Recruiting	`NCT04420442` - Scar Resection and Reconstruction With Integra and Split Skin Grafts in Patients With Non-Suicidal Self-Inflicted Scars	N/A
Completed	`NCT02772289` - Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section Scars	Phase 2
Completed	`NCT00430326` - Juvista (Avotermin) in Scars Following Varicose Vein Removal	Phase 2
Completed	`NCT00847925` - Safety and Efficacy of RN1001(Avotermin) in Healthy Male Subjects	Phase 1/Phase 2
Recruiting	`NCT05787171` - Three Sutures With Different Absorption Rates for Lower Abdominal Incision	N/A
Completed	`NCT02985151` - Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy	N/A
Completed	`NCT02340325` - FS2 Safety and Tolerability Study in Healthy Volunteers	Phase 1
Active, not recruiting	`NCT00432211` - Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.	Phase 2
Completed	`NCT00978302` - Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)	Phase 1